宣泰医药：奥拉帕利片拟中选第十一批全国药品集中采购

Core Viewpoint - XuanTai Pharmaceutical (688247) announced participation in the 11th national centralized drug procurement organized by the National Organization for Drug Procurement Office, with its product Olaparib tablets proposed for selection in this procurement [1] Group 1 - The company participated in the national centralized drug procurement bidding on October 29 [1] - The proposed selection results were published on October 28, 2025 [1] - The product Olaparib tablets is set to be included in this centralized procurement [1]